FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.

The EU approves belantamab mafodotin combinations, enhancing treatment options for relapsed multiple myeloma patients with ...

Anyone who has submitted a medical device for pre-market review knows the financial investment it takes to for FDA to conduct ...

Back in 2010, Jeffrey Epstein stayed silent and invoked his rights instead of admitting whether he and Donald Trump ...